The diagnosis of PH1 was confirmed by genetic testing with compound heterozygous pathogenic variants c.568G > A (p.Pro11Leu) and c.121G > A (p.Gly41Arg) in the AGXT gene. Here, AGXT is linked to primary hyperoxaluria type 1.